Fresenius Kabi launches Omegaven for pediatric patients with parenteral nutrition-associated cholestasis in US
Fresenius Kabi, a prominent German pharmaceutical company, has introduced Omegaven (fish oil triglycerides) injectable emulsion in the United States, targeting a critical need for pediatric patients suffering from parenteral nutrition-associated cholestasis (PNAC). This launch marks Omegaven as the first and only FDA-approved fish oil lipid emulsion specifically designed for children with PNAC, expanding its availability […]